Total Payments
$682,018
2024 Payments
$63,580
Companies
23
Transactions
830
Medicare Patients
742
Medicare Billing
$64,389
Payment Breakdown by Category
Other$583,099 (85.5%)
Consulting$41,887 (6.1%)
Travel$35,970 (5.3%)
Food & Beverage$20,921 (3.1%)
Education$100.69 (0.0%)
Gifts$40.59 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $516,223 | 252 | 75.7% |
| Honoraria | $66,876 | 28 | 9.8% |
| Consulting Fee | $41,887 | 29 | 6.1% |
| Travel and Lodging | $35,970 | 188 | 5.3% |
| Food and Beverage | $20,921 | 317 | 3.1% |
| Education | $100.69 | 15 | 0.0% |
| Gift | $40.59 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $164,935 | 169 | $0 (2019) |
| GlaxoSmithKline, LLC. | $119,621 | 111 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $85,477 | 77 | $0 (2024) |
| ABBVIE INC. | $58,333 | 119 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $52,440 | 79 | $0 (2024) |
| Horizon Pharma plc | $49,412 | 34 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $35,913 | 57 | $0 (2024) |
| Amgen Inc. | $32,423 | 48 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $30,787 | 32 | $0 (2024) |
| Horizon Therapeutics plc | $20,614 | 22 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $63,580 | 93 | Mallinckrodt Hospital Products Inc. ($27,827) |
| 2023 | $77,820 | 110 | AstraZeneca Pharmaceuticals LP ($18,210) |
| 2022 | $86,556 | 106 | Mallinckrodt Hospital Products Inc. ($20,924) |
| 2021 | $51,366 | 52 | GlaxoSmithKline, LLC. ($24,671) |
| 2020 | $70,613 | 56 | GlaxoSmithKline, LLC. ($30,985) |
| 2019 | $156,390 | 179 | Mallinckrodt Enterprises LLC ($98,058) |
| 2018 | $93,099 | 114 | Horizon Pharma plc ($35,000) |
| 2017 | $82,595 | 120 | Mallinckrodt LLC ($38,666) |
All Payment Transactions
830 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/23/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,440.00 | General |
| 12/12/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $26.80 | General |
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Travel and Lodging | In-kind items and services | $120.60 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $8.07 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,080.00 | General |
| Category: RESPIRATORY | ||||||
| 11/29/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | Cash or cash equivalent | $147.40 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $124.03 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $103.20 | General |
| 11/07/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/30/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/29/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Travel and Lodging | Cash or cash equivalent | $53.60 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Travel and Lodging | In-kind items and services | $217.35 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,100.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $975.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $48.26 | General |
| Category: Inflammation | ||||||
| 09/17/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Travel and Lodging | In-kind items and services | $355.10 | General |
| Category: Inflammation and Autoimmunity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 110 | 165 | $33,420 | $12,874 |
| 2022 | 3 | 136 | 205 | $38,715 | $14,466 |
| 2021 | 5 | 209 | 291 | $48,249 | $18,296 |
| 2020 | 6 | 287 | 353 | $57,176 | $18,753 |
Total Patients
742
Total Services
1,014
Medicare Billing
$64,389
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 128 | $27,648 | $10,886 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 37 | $5,772 | $1,988 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 126 | $27,216 | $10,037 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 54 | $8,424 | $2,916 | 34.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 16 | 25 | $3,075 | $1,513 | 49.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 71 | 111 | $23,976 | $9,940 | 41.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 101 | $15,756 | $5,225 | 33.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 34 | 43 | $5,289 | $2,245 | 42.4% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 11 | 15 | $3,018 | $792.00 | 26.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 12 | 21 | $210.00 | $95.22 | 45.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 92 | 115 | $18,483 | $8,073 | 43.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 65 | 81 | $17,496 | $5,320 | 30.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 87 | 110 | $17,160 | $4,623 | 26.9% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 11 | 12 | $2,382 | $513.13 | 21.5% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 18 | 18 | $1,485 | $151.37 | 10.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 14 | 17 | $170.00 | $72.99 | 42.9% |
About Dr. David Batt, MD
Dr. David Batt, MD is a Internal Medicine healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972547529.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Batt, MD has received a total of $682,018 in payments from pharmaceutical and medical device companies, with $63,580 received in 2024. These payments were reported across 830 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($516,223).
As a Medicare-enrolled provider, Batt has provided services to 742 Medicare beneficiaries, totaling 1,014 services with total Medicare billing of $64,389. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology, Rheumatology
- Location Indianapolis, IN
- Active Since 06/15/2006
- Last Updated 05/13/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1972547529
Products in Payments
- ACTHAR (Biological) $250,412
- BENLYSTA (Biological) $119,503
- KRYSTEXXA (Drug) $49,301
- SAPHNELO (Biological) $35,886
- OFEV (Drug) $32,991
- LUPKYNIS (Drug) $30,787
- KRYSTEXXA (Biological) $20,552
- Tavneos (Drug) $18,397
- Humira (Biological) $15,355
- DUZALLO (Drug) $14,223
- Rinvoq (Biological) $13,764
- TAVNEOS (Drug) $13,029
- Cimzia (Drug) $10,419
- ZURAMPIC (Drug) $4,098
- HUMIRA (Biological) $1,950
- COSENTYX (Biological) $1,316
- RINVOQ (Drug) $1,092
- RINVOQ (Biological) $622.33
- Otezla (Drug) $517.04
- ORENCIA (Biological) $217.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Indianapolis
Rafat Abonour, Md, MD
Internal Medicine — Payments: $833,709
Internal Medicine $833,709
Ashwin Ravichandran, Md, MD
Internal Medicine — Payments: $398,583
Internal Medicine $398,583
John Miller, Md, MD
Internal Medicine — Payments: $325,524
Internal Medicine $325,524
Naga Chalasani, Md, MD
Internal Medicine — Payments: $303,095
Internal Medicine $303,095
James Trippi, Md, MD
Internal Medicine — Payments: $280,481
Internal Medicine $280,481
Dr. Woodrow Corey, Md, MD
Internal Medicine — Payments: $262,512
Internal Medicine $262,512